{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:41:11Z","timestamp":1763037671732},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00277-021-04644-3","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T19:39:18Z","timestamp":1632512358000},"page":"69-79","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India"],"prefix":"10.1007","volume":"101","author":[{"given":"Anshul","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihar","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Sanjeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soniya","family":"Nityanand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zia","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"4644_CR1","unstructured":"Coronavirus Update (Live): 9,63,04429 cases and 17,95178 deaths from COVID-19 virus pandemic - worldometer [Internet]. [last accessed on 20th July 2021]. Available from: https:\/\/www.worldometers.info\/coronavirus\/#countries"},{"key":"4644_CR2","doi-asserted-by":"publisher","first-page":"104357","DOI":"10.1016\/j.jcv.2020.104357","volume":"127","author":"JA Siordia Jr","year":"2020","unstructured":"Siordia JA Jr (2020) Epidemiology and clinical features of COVID-19: a review of current literature. J Clin Virol 127:104357. https:\/\/doi.org\/10.1016\/j.jcv.2020.104357","journal-title":"J Clin Virol"},{"key":"4644_CR3","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.4103\/jfmpc.jfmpc_424_20","volume":"9","author":"KK Sahu","year":"2020","unstructured":"Sahu KK, Kumar R (2020) Current perspective on pandemic of COVID-19 in the United States. J Fam Med Prim Care 9:1784\u20131791. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_424_20","journal-title":"J Fam Med Prim Care"},{"key":"4644_CR4","doi-asserted-by":"publisher","first-page":"m1198","DOI":"10.1136\/bmj.m1198","volume":"368","author":"RE Jordan","year":"2020","unstructured":"Jordan RE, Adab P, Cheng KK (2020) Covid-19: risk factors for severe disease and death. BMJ 368:m1198. https:\/\/doi.org\/10.1136\/bmj.m1198","journal-title":"BMJ"},{"key":"4644_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.14740\/jocmr3617w","volume":"10","author":"S Roy","year":"2018","unstructured":"Roy S, Vallepu S, Barrios C, Hunter K (2018) Comparison of comorbid conditions between cancer survivors and age-matched patients without cancer. J Clin Med Res. 10:911\u20139. https:\/\/doi.org\/10.14740\/jocmr3617w","journal-title":"J Clin Med Res."},{"key":"4644_CR6","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3389\/fonc.2020.01439","volume":"10","author":"A Isidori","year":"2020","unstructured":"Isidori A, de Leval L, Gergis U, Musto P, Porcu P (2020) Management of patients with hematologic malignancies during the COVID-19 pandemic: practical considerations and lessons to be learned. Front Oncol 10:1439. https:\/\/doi.org\/10.3389\/fonc.2020.01439","journal-title":"Front Oncol"},{"key":"4644_CR7","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1182\/blood.2020008824","volume":"136","author":"A Vijenthira","year":"2020","unstructured":"Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, Mart\u00edn-Moro F, Razanamahery J, Riches JC, Zwicker J, Patell R, Vekemans MC, Scarf\u00f2 L, Chatzikonstantinou T, Yildiz H, Lattenist R, Mantzaris I, Wood WA, Hicks LK (2020) Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood 136:2881\u20132892. https:\/\/doi.org\/10.1182\/blood.2020008824","journal-title":"Blood"},{"key":"4644_CR8","unstructured":"Ministry of Health & family Welfare. Clinical management protocol: COVID-19 version 5 [Internet]. Mohfw.gov.in (web archive link, 23 October 2020). 2020 [cited 23 October 2020]. Available from: https:\/\/www.mohfw.gov.in\/pdf\/UpdatedClinicalManagementProtocolforCOVID-19dated03072020.pdf"},{"key":"4644_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.dsx.2020.07.037","volume":"14","author":"AA Salunke","year":"2020","unstructured":"Salunke AA, Nandy K, Pathak SK et al (2020) Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: a systematic review and meta-analysis. Diabetes Metab Syndr 14:1431\u20131437. https:\/\/doi.org\/10.1016\/j.dsx.2020.07.037","journal-title":"Diabetes Metab Syndr"},{"key":"4644_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/GO.20.00097","volume":"6","author":"A Desai","year":"2020","unstructured":"Desai A, Sachdeva S, Parekh T, Desai R (2020) Covid-19 and cancer: lessons from a pooled metaanalysis. JCO Glob Oncol 6:557\u2013559. https:\/\/doi.org\/10.1200\/GO.20.00097","journal-title":"JCO Glob Oncol"},{"key":"4644_CR11","doi-asserted-by":"publisher","first-page":"S1658","DOI":"10.1016\/j.hemonc.2020.07.005","volume":"30","author":"GM ElGohary","year":"2020","unstructured":"ElGohary GM, Hashmi S, Styczynski J, Kharfan-Dabaja MA, Alblooshi RM, de la C\u00e1mara R, Mohmed S, Alshaibani A, Cesaro S, Abd El-Aziz N, Almaghrabi R, Gergis U, Majhail NS, El-Gohary Y, Chemaly RF, Aljurf M, El Fakih R (2020) The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 30:S1658-3876(20)30122\u20139. https:\/\/doi.org\/10.1016\/j.hemonc.2020.07.005","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"4644_CR12","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/j.jinf.2020.05.062","volume":"81","author":"ZM Afshar","year":"2020","unstructured":"Afshar ZM, Dayani M, Naderi M, Ghanbarveisi F, Shiri S, Rajati F (2020) Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis. J Infect 81:e114\u2013e116. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.062","journal-title":"J Infect"},{"key":"4644_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.46619\/Cmj.2020.3-1019","volume":"3","author":"R Patel","year":"2020","unstructured":"Patel R, Park J, Shah A, Saif MW (2020) COVID-19 and cancer patients. Cancer Med J 3:40\u201348","journal-title":"Cancer Med J"},{"key":"4644_CR14","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","volume":"34","author":"W He","year":"2020","unstructured":"He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP (2020) COVID-19 in persons with haematological cancers. Leukemia 34:1637\u20131645. https:\/\/doi.org\/10.1038\/s41375-020-0836-7","journal-title":"Leukemia"},{"key":"4644_CR15","doi-asserted-by":"publisher","first-page":"102525","DOI":"10.1016\/j.bcmd.2020.102525","volume":"87","author":"P Borah","year":"2021","unstructured":"Borah P, Mirgh S, Sharma SK, Bansal S, Dixit A, Dolai TK, Lunkad S, Gupta N, Singh G, Jain A, Bansal D, Choudhary D, Khandelwal V, Doval D, Kumar M, Bhargava R, Chakrabarti A, Kalashetty M, Rauthan A, Kazi B, Mandal PK, Jeyaraman P, Naithani R, AIIMS Hematology Alumni Group (2021) Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies. Blood Cells Mol Dis 87:102525","journal-title":"Blood Cells Mol Dis"},{"key":"4644_CR16","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1111\/bjh.16758","volume":"190","author":"R Fo\u00e0","year":"2020","unstructured":"Fo\u00e0 R, Bonifacio M, Chiaretti S, Curti A, Candoni A, Fava C, Ciccone M, Pizzolo G, Ferrara F (2020) Philadelphia-positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID-19 pandemic: a Campus ALL study. Br J Haematol 190:e3\u2013e5. https:\/\/doi.org\/10.1111\/bjh.16758","journal-title":"Br J Haematol"},{"key":"4644_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1182\/blood.2020006854","volume":"136","author":"A Cuneo","year":"2020","unstructured":"Cuneo A, Scarf\u00f2 L, Reda G, Varettoni M, Quaglia FM, Marchetti M, De Paoli L, Re F, Pietrasanta D, Rigolin GM, Orsucci L, Ibatici A, Gattei V, Mauro FR, Trentin L, Laurenti L, Marasca R, Fo\u00e0 R (2020) Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. Blood 136:763\u2013766. https:\/\/doi.org\/10.1182\/blood.2020006854","journal-title":"Blood"},{"key":"4644_CR18","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1038\/s41375-020-0904-z","volume":"34","author":"M Breccia","year":"2020","unstructured":"Breccia M, Abruzzese E, Bocchia M, Bonifacio M, Castagnetti F, Fava C, Galimberti S, Gozzini A, Gugliotta G, Iurlo A, Latagliata R, Luciano L, Pregno P, Rege-Cambrin G, Rosti G, Stagno F, Tiribelli M, Fo\u00e0 R, Saglio G, Campus CML working group (2020) Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey. Leukemia 34:2260\u20132261. https:\/\/doi.org\/10.1038\/s41375-020-0904-z","journal-title":"Leukemia"},{"key":"4644_CR19","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1182\/bloodadvances.2020003170","volume":"4","author":"WA Wood","year":"2020","unstructured":"Wood WA, Neuberg DS, Thompson JC, Tallman MS, Sekeres MA, Sehn LH, Anderson KC, Goldberg AD, Pennell NA, Niemeyer CM, Tucker E, Hewitt K, Plovnick RM, Hicks LK (2020) Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub. Blood Adv 4:5966\u20135975. https:\/\/doi.org\/10.1182\/bloodadvances.2020003170","journal-title":"Blood Adv"},{"key":"4644_CR20","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1634\/theoncologist.2020-0572","volume":"26","author":"KA Lee","year":"2021","unstructured":"Lee KA, Ma W, Sikavi DR, Drew DA, Nguyen LH, Bowyer RCE, Cardoso MJ, Fall T, Freidin MB, Gomez M, Graham M, Guo CG, Joshi AD, Kwon S, Lo CH, Lochlainn MN, Menni C, Murray B, Mehta R, Song M, Sudre CH, Bataille V, Varsavsky T, Visconti A, Franks PW, Wolf J, Steves CJ, Ourselin S, Spector TD, Chan AT, COPE consortium (2021) Cancer and risk of COVID-19 through a general community survey. Oncologist 26:2020\u201336. https:\/\/doi.org\/10.1634\/theoncologist.2020-0572","journal-title":"Oncologist"},{"key":"4644_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21:335\u2013337. https:\/\/doi.org\/10.1016\/S1470-2045(20)30096-6","journal-title":"Lancet Oncol"},{"key":"4644_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12288-020-01318-4","volume":"37","author":"R Lattenist","year":"2020","unstructured":"Lattenist R, Yildiz H, De Greef J, Bailly S, Yombi JC (2020) COVID-19 in adult patients with hematological disease: analysis of clinical characteristics and outcomes. Indian J Hematol Blood Transfus 37:1\u20135. https:\/\/doi.org\/10.1007\/s12288-020-01318-4","journal-title":"Indian J Hematol Blood Transfus"},{"key":"4644_CR23","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1111\/bjh.16935","volume":"190","author":"V Shah","year":"2020","unstructured":"Shah V, KoKo T, Zuckerman M, Vidler J, Sharif S, Mehra V, Gandhi S, Kuhnl A, Yallop D, Avenoso D, Rice C, Sanderson R, Sarma A, Marsh J, de Lavallade H, Krishnamurthy P, Patten P, Benjamin R, Potter V, Ceesay MM, Mufti GJ, Norton S, Pagliuca A, Galloway J, Kulasekararaj AG (2020) Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King\u2019s College Hospital experience. Br J Haematol 190:e279\u2013e282. https:\/\/doi.org\/10.1111\/bjh.16935","journal-title":"Br J Haematol"},{"key":"4644_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, Xiong Y, Xiong H, Wang C, Chen C, Xiong F, Zhang Y, Peng Y, Ge S, Zhen B, Yu T, Wang L, Wang H, Liu Y, Chen Y, Mei J, Gao X, Li Z, Gan L, He C, Li Z, Shi Y, Qi Y, Yang J, Tenen DG, Chai L, Mucci LA, Santillana M, Cai H (2020) Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10:783\u2013791. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0422","journal-title":"Cancer Discov"},{"key":"4644_CR25","doi-asserted-by":"publisher","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","volume":"7","author":"F Passamonti","year":"2020","unstructured":"Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, Angelucci E, Krampera M, Cairoli R, Della Porta MG, Fracchiolla N, Ladetto M, GambacortiPasserini C, Salvini M, Marchetti M, Lemoli R, Molteni A, Busca A, Cuneo A, Romano A, Giuliani N, Galimberti S, Corso A, Morotti A, Falini B, Billio A, Gherlinzoni F, Visani G, Tisi MC, Tafuri A, Tosi P, Lanza F, Massaia M, Turrini M, Ferrara F, Gurrieri C, Vallisa D, Martelli M, Derenzini E, Guarini A, Conconi A, Cuccaro A, Cudillo L, Russo D, Ciambelli F, Scattolin AM, Luppi M, Selleri C, Ortu La Barbera E, Ferrandina C, Di Renzo N, Olivieri A, Bocchia M, Gentile M, Marchesi F, Musto P, Federici AB, Candoni A, Venditti A, Fava C, Pinto A, Galieni P, Rigacci L, Armiento D, Pane F, Oberti M, Zappasodi P, Visco C, Franchi M, Grossi PA, Bert\u00f9 L, Corrao G, Pagano L, Corradini P, ITA-HEMA-COV Investigators (2020) Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol 7:e737\u2013e745. https:\/\/doi.org\/10.1016\/S2352-3026(20)30251-9","journal-title":"Lancet Haematol"},{"key":"4644_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Geng M, Peng Y, Meng L, Lu S (2020) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10:102\u2013108. https:\/\/doi.org\/10.1016\/j.jpha.2020.03.001","journal-title":"J Pharm Anal"},{"key":"4644_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13045-020-00970-7","volume":"13","author":"J Garc\u00eda-Su\u00e1rez","year":"2020","unstructured":"Garc\u00eda-Su\u00e1rez J, de la Cruz J, Cedillo \u00c1, Llamas P, Duarte R, Jim\u00e9nez-Yuste V, Hern\u00e1ndez-Rivas J\u00c1, Gil-Manso R, Kwon M, S\u00e1nchez-Godoy P, Mart\u00ednez-Barranco P, Col\u00e1s-Lahuerta B, Herrera P, Benito-Parra L, Alegre A, Velasco A, Matilla A, Al\u00e1ez-Us\u00f3n MC, Martos-Mart\u00ednez R, Mart\u00ednez-Chamorro C, Susana-Quiroz K, Del Campo JF, de la Fuente A, Herr\u00e1ez R, Pascual A, G\u00f3mez E, P\u00e9rez-Oteyza J, Ruiz E, Alonso A, Gonz\u00e1lez-Medina J, Mart\u00edn-Buitrago LN, Canales M, Gonz\u00e1lez-Gasc\u00f3n I, Vicente-Ayuso MC, Valenciano S, Roa MG, Monteliu PE, L\u00f3pez-Jim\u00e9nez J, Escobar CE, Ortiz-Mart\u00edn J, Diez-Martin JL, Martinez-Lopez J, Asociaci\u00f3nMadrile\u00f1a de Hematolog\u00eda y Hemoterapia (AMHH) (2020) Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol 13:133. https:\/\/doi.org\/10.1186\/s13045-020-00970-7","journal-title":"J Hematol Oncol"},{"key":"4644_CR28","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/jmv.26404","volume":"93","author":"TN Yigenoglu","year":"2021","unstructured":"Yigenoglu TN, Ata N, Altuntas F, Basc\u0131 S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hac\u0131bekiroglu T, Dogu MH, Berber \u0130, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Imrat E, Birinci S (2021) The outcome of COVID-19 in patients with hematological malignancy. J Med Virol 93:1099\u20131104. https:\/\/doi.org\/10.1002\/jmv.26404","journal-title":"J Med Virol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04644-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T15:07:47Z","timestamp":1641222467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04644-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4644"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04644-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has been approved by Institution Ethics Committee (IEC No. 2020\u20135-EMP-118).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent has been taken from all patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"This is the original research and all figures, diagrams, schemes, tables, and text in this manuscript are our own, original, unpublished work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}